Wickham Laboratories, the specialist in microbiology and toxicology for the medical device and pharmaceutical industries, will attent Making Pharmaceutical Europe Conference 2018.
Held at the Brussels Expo centre on 13-14 March, the event offers a free to attend exhibition and conference featuring many companies involved within the pharmaceutical industry.
This will be the exhibition’s inaugural event in Europe and Wickham Labs will be supporting the expansion of the Making Pharmaceuticals tradeshow.
Dr Lynne Murdoch, Head of Microbiology at Wickham, will be contributing to the conference seminar programme with a discussion on the merits of rapid microbiological testing. The presentation, MALDI-ToF in Practice; Validated Application of a Rapid Microbiological Method, will take place on 13 March at 10:10am, Room B of the Brussels Expo.
Delegates are invited to join Dr Murdoch in the discussion on MALDI-ToF as a quicker and more reliable method of microbial identification or visit stand 408 to discuss specific contract testing requirements in further detail.
Company overview
As a GMP/GLP compliant laboratory with over 50 years of experience, Wickham Laboratories Ltd is an established name in the fields of pharmaceutical and medical device contract testing, research and consultancy. Wickham engages with clients worldwide and the combined expertise of laboratory technicians and managers enables the company to be fully conversant with global regulatory expectations.
Committed to providing a quality testing service, combining high levels of client satisfaction together with the maintenance of appropriate accreditation.
Wickham is routinely inspected by the MHRA, FDA and Home Office, and offer the opportunity for clients to conduct audits on a regular basis.
